South Korean health-tech company 815MNB announced it will display its Neuraon Assist wellness headband at CES 2027 in Las Vegas FinancialContent1.
The device uses noninvasive vagus nerve stimulation adjusted by real-time biometric feedback to help users relax or prepare for sleep FinancialContent1. The company claims the headband automatically adjusts stimulation without user input, a distinction from wearables that track stress metrics but require manual interpretation FinancialContent1.
According to the press release, the headband monitors heart rate and heart rate variability against a user’s personal baseline FinancialContent1. The device then delivers gentle stimulation and measures the physiological response to dynamically adjust subsequent levels FinancialContent1.
William Marcel Sauve, 815MNB’s chief technology officer, said conventional wearables leave users to figure out what to do with their stress data FinancialContent1. "Neuraon Assist was born out of that familiar frustration," Sauve said. "Instead of adding another layer of data to analyze, it eases that burden by automatically adjusting stimulation while the wearer simply takes a break" FinancialContent1.
The announcement does not include pricing, battery life specifications, or independent test results FinancialContent1. It is unclear whether the device requires FDA clearance for its claimed wellness benefits.
Beyond consumer wellness, 815MNB stated it is expanding research into therapeutic applications for developmental disabilities, cognitive health in older adults, and post-traumatic stress disorder FinancialContent1. The company also listed behavioral and substance addictions as areas of current research FinancialContent1. 815MNB expects to begin launching clinical products in 2028 FinancialContent1.